Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1379394 | Bioorganic & Medicinal Chemistry Letters | 2005 | 6 Pages |
Abstract
A novel series of dual EGFR and HER2 inhibitors based on the pyrrolo[2,1-f][1,2,4]triazine nucleus is described. A general route toward their synthesis, which enables functionalization at multiple sites, has been developed. Biological evaluation in enzymatic and cell-based assays has identified a series of C-6 carbamates with potent biochemical and cellular activities.
Graphical abstractA novel series of dual EGFR and HER2 inhibitors based on the pyrrolo[2,1-f][1,2,4]triazine nucleus is described. Biological evaluation in enzymatic and cell-based assays has identified a series of C-6 carbamates with potent biochemical and cellular activities.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Brian E. Fink, Gregory D. Vite, Harold Mastalerz, John F. Kadow, Soong-Hoon Kim, Kenneth J. Leavitt, Karen Du, Donald Crews, Toomas Mitt, Tai W. Wong, John T. Hunt, Dolatrai M. Vyas, John S. Tokarski,